Capital Expenditures - CJ Bioscience Inc (KOSDAQ:311690) - Alpha Spread
C

CJ Bioscience Inc
KOSDAQ:311690

Watchlist Manager
CJ Bioscience Inc
KOSDAQ:311690
Watchlist
Price: 12 000 KRW 1.1% Market Closed
Market Cap: 109.4B KRW
Have any thoughts about
CJ Bioscience Inc?
Write Note

CJ Bioscience Inc
Capital Expenditures

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

CJ Bioscience Inc
Capital Expenditures Peer Comparison

Comparables:
U
032620
D
315640
e
099750
L
328130
J
322510

Competitive Capital Expenditures Analysis
Latest Figures & CAGR of Competitors

Company Capital Expenditures CAGR 3Y CAGR 5Y CAGR 10Y
C
CJ Bioscience Inc
KOSDAQ:311690
Capital Expenditures
-â‚©16.4B
CAGR 3-Years
5%
CAGR 5-Years
-154%
CAGR 10-Years
N/A
U
UBCare Co Ltd
KOSDAQ:032620
Capital Expenditures
-â‚©2.6B
CAGR 3-Years
11%
CAGR 5-Years
-14%
CAGR 10-Years
-22%
D
DeepNoid Inc
KOSDAQ:315640
Capital Expenditures
-â‚©815.6m
CAGR 3-Years
-12%
CAGR 5-Years
-51%
CAGR 10-Years
N/A
e
ezCaretech Co Ltd
KOSDAQ:099750
Capital Expenditures
-â‚©349.8m
CAGR 3-Years
64%
CAGR 5-Years
39%
CAGR 10-Years
N/A
L
Lunit Inc
KOSDAQ:328130
Capital Expenditures
-â‚©1.6B
CAGR 3-Years
-23%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
J
JLK Inc
KOSDAQ:322510
Capital Expenditures
-â‚©364.4m
CAGR 3-Years
69%
CAGR 5-Years
13%
CAGR 10-Years
N/A

See Also

What is CJ Bioscience Inc's Capital Expenditures?
Capital Expenditures
-16.4B KRW

Based on the financial report for Dec 31, 2023, CJ Bioscience Inc's Capital Expenditures amounts to -16.4B KRW.

What is CJ Bioscience Inc's Capital Expenditures growth rate?
Capital Expenditures CAGR 5Y
-154%

Over the last year, the Capital Expenditures growth was -237%. The average annual Capital Expenditures growth rates for CJ Bioscience Inc have been 5% over the past three years , -154% over the past five years .

Back to Top